Healios K.K. (4593.T)
JPY 278.0
(3.35%)
JPY 278.0
(3.35%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 450 Million JPY | -88.78% |
| 2022 | 4.01 Billion JPY | -43.48% |
| 2021 | 7.09 Billion JPY | -37.1% |
| 2020 | 11.28 Billion JPY | -1.9% |
| 2019 | 11.5 Billion JPY | 355.09% |
| 2018 | 2.52 Billion JPY | 14.92% |
| 2017 | 2.19 Billion JPY | -7.25% |
| 2016 | 2.37 Billion JPY | 0.0% |
| 2015 | - JPY | 0.0% |
| 2014 | - JPY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 450 Million JPY | 0.0% |
| 2024 Q2 | 2.04 Billion JPY | 355.33% |
| 2023 Q2 | 3.97 Billion JPY | -0.4% |
| 2023 Q4 | 450 Million JPY | 1945.45% |
| 2023 FY | 450 Million JPY | -88.78% |
| 2023 Q3 | 22 Million JPY | -99.45% |
| 2023 Q1 | 3.99 Billion JPY | -0.42% |
| 2022 Q3 | 7.02 Billion JPY | -2.17% |
| 2022 Q2 | 7.18 Billion JPY | -0.72% |
| 2022 Q1 | 7.23 Billion JPY | 1.94% |
| 2022 FY | 4.01 Billion JPY | -43.48% |
| 2022 Q4 | 4.01 Billion JPY | -42.91% |
| 2021 Q1 | 11.37 Billion JPY | 0.8% |
| 2021 FY | 7.09 Billion JPY | -37.1% |
| 2021 Q4 | 7.09 Billion JPY | 1.81% |
| 2021 Q2 | 11.47 Billion JPY | 0.95% |
| 2021 Q3 | 6.97 Billion JPY | -39.28% |
| 2020 Q1 | 10.52 Billion JPY | -8.48% |
| 2020 Q2 | 9.1 Billion JPY | -13.47% |
| 2020 Q3 | 8.19 Billion JPY | -10.05% |
| 2020 Q4 | 11.28 Billion JPY | 37.71% |
| 2020 FY | 11.28 Billion JPY | -1.9% |
| 2019 Q3 | 11.5 Billion JPY | 360.0% |
| 2019 FY | 11.5 Billion JPY | 355.09% |
| 2019 Q2 | 2.5 Billion JPY | 0.0% |
| 2019 Q1 | 2.5 Billion JPY | -1.07% |
| 2019 Q4 | 11.5 Billion JPY | 0.0% |
| 2018 FY | 2.52 Billion JPY | 14.92% |
| 2018 Q2 | 1.61 Billion JPY | 933.97% |
| 2018 Q4 | 2.52 Billion JPY | 60.96% |
| 2018 Q1 | 156 Million JPY | -92.91% |
| 2018 Q3 | 1.57 Billion JPY | -2.67% |
| 2017 Q2 | 2.28 Billion JPY | -1.85% |
| 2017 Q3 | 2.24 Billion JPY | -1.88% |
| 2017 Q1 | 2.32 Billion JPY | -1.81% |
| 2017 Q4 | 2.19 Billion JPY | -1.92% |
| 2017 FY | 2.19 Billion JPY | -7.25% |
| 2016 FY | 2.37 Billion JPY | 0.0% |
| 2016 Q2 | 2.5 Billion JPY | 0.0% |
| 2016 Q1 | 2.5 Billion JPY | 0.0% |
| 2016 Q4 | 2.37 Billion JPY | -1.78% |
| 2016 Q3 | 2.41 Billion JPY | -3.44% |
| 2015 Q4 | - JPY | 0.0% |
| 2015 Q2 | - JPY | 0.0% |
| 2015 FY | - JPY | 0.0% |
| 2015 Q3 | - JPY | 0.0% |
| 2014 FY | - JPY | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 767.03 Million JPY | 41.332% |
| PRISM BioLab Co.,LTD | - JPY | -Infinity% |
| GNI Group Ltd. | 2 Billion JPY | 77.5% |
| Linical Co., Ltd. | 1.49 Billion JPY | 69.999% |
| Trans Genic Inc. | 1.32 Billion JPY | 66.091% |
| MEDINET Co., Ltd. | 781 Thousand JPY | -57518.438% |
| Soiken Holdings Inc. | - JPY | -Infinity% |
| Cytori Cell Research Institute, Inc. | 2.34 Billion JPY | 80.827% |
| AnGes, Inc. | 214.94 Million JPY | -109.352% |
| OncoTherapy Science, Inc. | 106.84 Million JPY | -321.155% |
| Nxera Pharma Co., Ltd. | 63.21 Billion JPY | 99.288% |
| Immuno-Biological Laboratories Co., Ltd. | 84.56 Million JPY | -432.16% |
| NanoCarrier Co., Ltd. | 1.1 Billion JPY | 59.42% |
| Carna Biosciences, Inc. | 28.4 Million JPY | -1484.395% |
| CanBas Co., Ltd. | - JPY | -Infinity% |
| D. Western Therapeutics Institute, Inc. | 875.59 Million JPY | 48.607% |
| RaQualia Pharma Inc. | 39.05 Million JPY | -1052.369% |
| Chiome Bioscience Inc. | - JPY | -Infinity% |
| Kidswell Bio Corporation | 1.83 Billion JPY | 75.516% |
| PeptiDream Inc. | 19.63 Billion JPY | 97.708% |
| Oncolys BioPharma Inc. | 161.1 Million JPY | -179.33% |
| Ribomic Inc. | - JPY | -Infinity% |
| SanBio Company Limited | 397 Million JPY | -13.35% |
| BrightPath Biotherapeutics Co., Ltd. | - JPY | -Infinity% |
| Kubota Pharmaceutical Holdings Co., Ltd. | - JPY | -Infinity% |
| Delta-Fly Pharma, Inc. | - JPY | -Infinity% |
| StemRIM | - JPY | -Infinity% |
| CellSource Co., Ltd. | 77.29 Million JPY | -482.215% |
| FunPep Company Limited | - JPY | -Infinity% |
| Kringle Pharma, Inc. | - JPY | -Infinity% |
| Stella Pharma Corporation | 773.29 Million JPY | 41.807% |
| TMS Co., Ltd. | - JPY | -Infinity% |
| Noile-Immune Biotech Inc. | - JPY | -Infinity% |
| Cuorips Inc. | - JPY | -Infinity% |
| K Pharma,Inc. | - JPY | -Infinity% |
| Takara Bio Inc. | 788 Million JPY | 42.893% |
| ReproCELL Incorporated | - JPY | -Infinity% |
| PhoenixBio Co., Ltd. | 491.35 Million JPY | 8.416% |
| StemCell Institute Inc. | 6.67 Million JPY | -6640.563% |
| Japan Tissue Engineering Co., Ltd. | - JPY | -Infinity% |
| CellSeed Inc. | 143.75 Million JPY | -213.043% |